Calypte Biomedical Corporation (CYPT) Launches Calypte Life Sciences Product Line
5/29/2008 10:33:28 AM
PORTLAND, Ore.--(BUSINESS WIRE)--Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced the launch of a new product line, Calypte Life Sciences. Calypte Life Sciences offers a broad range of recombinant proteins and antigens as well as proprietary reagents, buffers, and other specialty products to researchers and institutions seeking to develop and optimize immunodiagnostic assay systems. Calypte Life Sciences products are being distributed through a new on-line catalog (www.calyptelifesciences.com) as well as through Calypte’s established worldwide network of distributors.